General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines and Others): U.S. Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020.

U.S. general anxiety disorder market expected to reach USD 3,775 million by end of 2020, growing at a CAGR of 2.4% during 2015 and 2020.

14-Jul-2016 | Number of pages: 70 | Report Code: ZMR-34 | Report Format : | Status : Published

Analysis

General anxiety disorder (GAD) is characterized by constant and excessive worrying which is hard to control and lead to considerable impairment or distress. Other psychological symptoms of anxiety include irritability and apprehensiveness, and physical symptoms of anxiety are increased muscular tension and fatigue. Effective treatments for general anxiety disorder are medications and psychotherapy. Psychotherapy includes applied relaxation and cognitive-behavioral therapy among others.

According to anxiety and depression association of America, general anxiety disorder affects 3.1% of the U.S. population or 6.8 million adults, in any given year. U.S. stands for the major regional market for anxiety disorder therapeutics worldwide. Growing geriatric population and rising prevalence of anxiety disorders and depression are some of the key factors to drive the market in the years to come. Currently, U.S. general anxiety disorders market is saturated as a variety of antidepressant drugs are available on prescription for the similar symptom. Presently, general anxiety disorders market is on a decline owing to the weak pipeline of novel drugs, patent expiry of major antidepressants and an increasing number of cheap generic drug variants in the market.

Different therapeutic segments of the general anxiety disorder market include antidepressant, benzodiazepines and other therapeutics. The antidepressant was a major therapeutic segment of general anxiety disorder market and constituted 38.6% share of the total demand in 2014 and is expected to continue its dominance in the market over the forecast period. Numerous kinds of medications employed to treat general anxiety disorder. Antidepressants such as serotonin norepinephrine reuptake inhibitor (SNRI) and selective serotonin reuptake inhibitor (SSRI) classes are the first-line medication treatments. Benzodiazepines (clonazepam, alprazolam, diazepam, and lorazepam) are highly efficient in reducing muscular tension, promoting relaxation and other physical symptoms of anxiety.

General anxiety market is highly competitive in nature owing to the presence of both large and small pharmaceutical companies. Eli Lilly and Company, Sanofi S.A. Forest Laboratories, Inc., Johnson & Johnson H. Lundbeck A/S, Merck & Co., Inc., Pfizer, Inc. are some of the dominant players in the market space.


Related Reports

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.